Concepedia

Andrea Van Tuyl

AV

Statistics

Publications

4

Citations

75

H-Index

4

Active since

2008

Affiliations

BioMarin (United States)(Current)

Andrea Van Tuyl is an author at BioMarin (United States) specializing in life sciences, immunology, and antibody characterization.

ORCID

Publications per year

2008–2022

4

Publications

4

Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 study

Anu Cherukuri, Heather Cahan, Greg de Hart et al. · Clinical Immunology · 2018 · 36 citations

, , +3

Development, Validation, and Clinical Implementation of an Assay to Measure Total Antibody Response to Naglazyme® (Galsulfase)

Joleen T. White, Lisa Argento Martell, Andrea Van Tuyl et al. · The AAPS Journal · 2008 · 16 citations · Full text

, , +7

Comparison of Neutralizing Antibody Assays for Receptor Binding and Enzyme Activity of the Enzyme Replacement Therapeutic Naglazyme® (Galsulfase)

Joleen T. White, Lisa Argento Martell, William S. Prince et al. · The AAPS Journal · 2008 · 13 citations · Full text

, , +17

Lack of germline transmission in male mice following a single intravenous administration of AAV5-hFVIII-SQ gene therapy

Carlos Fonck, Cheng Su, Jeremy Arens et al. · Gene Therapy · 2022 · 10 citations · Full text

, , +14

1–4 of 4